CC
IBB icon

Centiva Capital’s iShares Biotechnology ETF IBB Stock Holding History

Centiva Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,000
Closed -$4.66M – 2003
2024
Q3 		$4.66M Buy
32,000
+9,300
+41% +$1.35M 0.09% 188
2024
Q2 		$3.12M Buy
+22,700
New +$3.03M 0.05% 253
2020
Q2 		– Sell
-2,800
Closed -$302K – 734
2020
Q1 		$302K Hold
2,800
– – 0.01% 387
2019
Q4 		$337K Buy
+2,800
New +$312K 0.02% 537
2019
Q1 		– Sell
-10,100
Closed -$974K – 338
2018
Q4 		$974K Sell
10,100
-19,900
-66% -$2.11M 0.08% 143
2018
Q3 		$3.66M Buy
+30,000
New +$3.53M 0.32% 50

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Centiva Capital's IBB Position: Q2 2026 in Review

Centiva Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3,000 shares — an estimated $507K sold.

Centiva Capital first reported a position in IBB in Q4 2018 and held it in 13 quarters. The position peaked at $17.6M in Q1 2020. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Centiva Capital reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 3,000 iShares Biotechnology ETF shares in Q2 2026, an estimated $507K.
  • Centiva Capital first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 13 quarters.
  • Centiva Capital's iShares Biotechnology ETF position peaked at $17.6M in Q1 2020.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.